XML 27 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Equity (Details) - USD ($)
 1 Months Ended 5 Months Ended 6 Months Ended
Mar. 04, 2021
Mar. 02, 2021
Oct. 16, 2020
Oct. 01, 2020
Apr. 01, 2020
Jul. 19, 2021
Nov. 20, 2020
Sep. 17, 2020
Jun. 30, 2021
Jun. 30, 2021
Equity (Details) [Line Items]                    
Ordinary shares issued                   (140)
Purchase agreement, description (i) one ADS of the Company, and (ii) a Series A Warrant to purchase an equal number of units purchased (the “2021 Series A Warrant”) and a Series B Warrant (the “2021 Series B Warrant”) to purchase half the number of units, and (b) 236,312 pre-funded units at a price of $7.069 per unit, consisting of (i) one pre-funded warrant to purchase one ADS and (ii) one 2021 Series A Warrant and one 2021 Series B Warrant.       the Company entered into a definitive securities purchase agreement (the “April 2020 Purchase Agreement”) with institutional investors to purchase 4,166,668 units, each consisting of (i) one pre-funded warrant to purchase one ADS and (ii) one Series B warrant to purchase one ADS, at a purchase price of $0.2999 per unit. The Series B warrants have an exercise price of $0.43 per ADS, are exercisable upon issuance and expire five years from the date of issuance. The offering resulted in gross proceeds to the Company of approximately $1.25 million. The closing of the sale of the securities took place on April 3, 2020. After the closing of the April 2020 Purchase Agreement and until the Approval Date, all pre-funded warrants were exercised. In addition, 4,161,668 of the Series B warrants were exercised pursuant to a cashless exercise mechanism as described in the April 2020 Purchase Agreement for no further consideration to the Company. As of the Approval Date, there were 5,000 Series B warrants unexercised.   (i) one ADS and (ii) two warrants to purchase one ADS each, at a purchase price of $5.02 per unit (“November 2020 Warrants”). The November 2020 Warrants have an exercise price of $5.02 per ADS, will be exercisable upon issuance and will expire five years from the date of issuance.      
Gross proceeds (in Dollars) $ 8,150,000           $ 4,200,000   $ 1,085,000  
Shares issued 916,316           835,447   14,000,000 14,000,000
Exercise of warrants                 216,100  
Shares issued 1,152,628               30,254,000  
Price per unit (in Dollars per share) $ 7.07                  
Warrant exercise price (in Dollars per share)                   $ 10.60
Exercise of pre-funded warrant                   100,000
Minimum [Member]                    
Equity (Details) [Line Items]                    
Ordinary shares issued   1,800,000,000                
Ordinary shares issued (in Dollars)     $ 750,000,000         $ 500,000,000    
Maximum [Member]                    
Equity (Details) [Line Items]                    
Ordinary shares issued   3,600,000,000                
Ordinary shares issued (in Dollars)     $ 1,800,000,000         $ 750,000,000    
ADS [Member]                    
Equity (Details) [Line Items]                    
Ordinary shares issued       140            
Warrant exercise price (in Dollars per share)                   $ 7.07
Non Adjusting Events [Member]                    
Equity (Details) [Line Items]                    
Ordinary shares issued           140